medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2020, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2020; 36 (2)

Exosomes: ''cell-free'' regenerative cell therapy

Rivero JRA

Language: Spanish
References: 35
Page: 1-10
PDF size: 0. Kb.


ABSTRACT

Mesenchymal/stromal cell‒based therapy is widely applied in modern medicine, even though not all survival and differentiation mechanisms are identified. However, a few years ago, extracellular elements began to be found that generate new paradigms. The present work explains the main characteristics and functions attributed to exosomes, nanoparticles made up of microvesicles secreted by with an effect on the extracellular matrix, and their impact as an alternative towards cell-free regenerative medicine. These structures participate, notoriously and critically, in intercellular communication, which has led to a change in the concept of the functions and role that these vesicles play within living organisms, particularly in the restoration of damaged tissues and the inflammatory and immunological response. Some examples of the exosomes’ biotechnological impact on companies and the biopharmaceutical market are discussed.


REFERENCES

  1. Caplan AI. Mesenchymal stem cells: time to change the name! Stem Cells Transl Med. 2017;6(6):1445-51.

  2. Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev. 2015;11(1):150-60.

  3. Camussi G, Deregibus MC and Cantaluppi V. Role of stem-cell-derivedmicrovesicles in theparacrineaction of stemcells. Biochem Soc Transac. 2013;41:283-7.

  4. Raposo G, Stoorvogel W. Extracellularvesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373-83.

  5. Bang C and Thum T. Exosomes: new players in cell-cellcommunication. Int J Biochem Cell Biol. 2012;44(11):2060-4.

  6. Chivet M, Javalet C, Hemming F, Pernet-Gallay K, Laulagnier K, Fraboulet S, et al. Exosomes as a novel way of interneuronal communication. Biochem Soc Trans. 2013; 41(1):241-4.

  7. Redis RS, Calin S, Yang Y, You MJ and Calin GA. Cell-to-cellmiRNA transfer: frombody homeostasis totherapy. Pharmacol Ther. 2012;136(2):169-74

  8. Clayton A. Cancercells use exosomes as tolstomanipulateimmunity and themicroenvironment. Oncoimmunol. 2012;1(1):78-80.

  9. Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226-32.

  10. Smalheiser NR Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct. 2007;2:35

  11. Johnstone RM. Exosomesbiologicalsignificance: a concisereview. Blood Cells Mol Dis. 2006;36:315-321.

  12. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011;6(4):481-92.

  13. György B1, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellularvesicles. Cell Mol Life Sci. 2011;68(16):2667-88.

  14. Katare R, Stroemer P, Hicks C, Stevanato L, Patel S, Corteling R, et al. Clinical-grade human neural stem cells promote reparative neovascularization in mouse models of hind limb ischemia. Arterioscler Thromb Vasc Biol. 2014;34(2):408-18.

  15. Babiy B. Exosomas, aproximación experimental y aplicaciones clínicas. (Tesis de Grado en Farmacia). Alcalá de Henares: Universidad de Alcalá; 2016

  16. Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. Exo Carta: a web-based compendium of Exosomal cargo. J Mol Biol. 2016;428(4):688-692.

  17. Schey KL, Luther JM, Rose KL. Proteomics characterization of exosome cargo. Methods. 2015;87:75-82.

  18. Yin K, Wang S, Chunhua-Zhao R. Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res. 2019;7:8.

  19. Li S, Yao J, Xie M, Liu Y, Zheng M. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses. J Hematol Oncol. 2018;11(1):54.

  20. Camussi G, Deregibus MC, Tetta C. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens. 2010;19(1):7-12.

  21. Eldh M, Ekström K, Valadi H, Sjöstrand M, Olsson B, Jernås M, et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PloSOne.2010;5:e15353.

  22. Shen M, Ren X. New insights into the biological impacts of immune cell-derived exosomes within the tumor environment. Cancer Letter. 2018;431:115-22.

  23. Gao L, Wang L, Dai T, Jin K, Zhang Z, Wang S, et al. Tumor-derived exosomes antagonize innate antiviral immunity. NatImmunol. 2018;19(3):233-45.

  24. Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5):1399-410.

  25. Di Trapani M, Bassi G, Midolo M, Gatti A, Kamga PT, Cassaro A, et al. Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions. Sci Rep. 2016;6:24120.

  26. Burrello J, Monticone S, Gai C, Gomez Y, Kholia S, Camussi G. Stemcell-derived extracellular vesicles and immune-modulation. Front Cell Dev Biol. 2016;4:83.

  27. Vrijsen KR, Maring JA, Chamuleau SA, Verhage V, Mol EA, Deddens JC, et al. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Health Mater. 2016;5(19):2555-65.

  28. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78 (9):838-48.

  29. Chaput N, Thery C. Exosomes: immuneproperties and potential clinical implementations. Semin Immunopathol. 2011;33(5):419-40.

  30. You L, Mao L, Wei J, Jin S, Yang C, Liu H, et al. The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses. J Hematol Oncol. 2017;10(1):165.

  31. Lai P, Chen X, Guo L, Wang Y, Liu X, Liu Y, et al. A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD. J Hematol Oncol. 2018;11(1):135.

  32. Shigemoto-Kuroda T, Oh JY, Kim DK, Jeong HJ, Park SY, Lee HJ, et al. MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and Uveoretinitis. Stem Cell Reports. 2017;8(5):1214-25.

  33. Du YM, Zhuansun YX, Chen R, Lin L, Lin Y, Li JG. Mesenchymal stem cell exosomes promote immune suppression of regulatory T cells in asthma. Exp Cell Res. 2018;363(1):114-20.

  34. Jung JW, Kwon M, Choi JC, Shin JW, Park IW, Choi BW, et al. Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy. Yonsei Med J. 2013;54(5):1293-6.

  35. Anónimo. Exosomas: terapia celular libre de células. Santiago de Chile: Cells For Cells. 3 Sept 2018 [acceso 14/10/2019]. Disponible en: Disponible en: http://www.c4c.cl/exosomas-terapia-celular-libre-celulas




2020     |     www.medigraphic.com